Search

Search Results

• Increased mortality in male recipients of red cells from ever pregnant female donors : mHAGs on red cells to blame ?

  Kanjaksha Ghosh

  e2018009

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.009

  2868

  PDF: 678

  HTML: 415

• THE IMPACT OF PRE-ANALYTICAL FACTORS ON BLOOD GLUCOSE MEASUREMENTS AND  and recommendations THE IMPACT OF PRE-ANALYTICAL FACTORS ON BLOOD GLUCOSE MEASUREMENTS AND RECOMMENDATIONS  FOR CLINICAL PRACTICE: AN ICET-A MULTICENTER SURVEY IN TRANSFUSION-DEPENDENT Β THALASSEMIA (Β-TDT) PATIENTS

  Vincenzo De Sanctis, Christos Kattamis, Duran Canatan, Defne Ay Tuncel, Sule Unal , Dulani Kottahachchi, Mohamed A Yassin, Ashraf T Soliman, Saif Al Yaarubi , Yasser Wali, Mehran Karimi, Forough Saki, Mohammad Faranoush, Polyxeni Delaporta, Antonis Kattamis, Iskra Modeva, Ploutarchos Tzoulis, Shahina Daar, Irene Savvidou

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.035

  407

  PDF: 407

  HTML: 45

• THE FREQUENCY OF ADRENAL INSUFFICIENCY IN ADOLESCENTS AND YOUNG ADULTS WITH THALASSEMIA MAJOR VERSUS THALASSEMIA INTERMEDIA IN IRAN

  Sara Matin, Masoud Ghanei Jahromi, Zohreh Karemizadeh, Sezaneh Haghpanah, Vincenzo De Sanctis, Ashraf Soliman, Mehran Karimi

  e2015005

  2014-08-28

  https://doi.org/10.4084/mjhid.2015.005

  2338

  PDF: 1112

  HTML: 9678

• Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy

  Antonella Vaccarino, Irene Dogliotti, Fabio Marletto, Andrea Demarchi, Mario Bazzan

  e2016050

  2016-10-20

  https://doi.org/10.4084/mjhid.2016.050

  2912

  PDF: 797

  HTML: 1306

  Blood Count trend before and during lenalidomide treatment: 201

  Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 210

• BACK TO THE “GOLD STANDARD”: HOW PRECISE IS HEMATOCRIT DETECTION TODAY? Novel ImageJ-based approach for the precise hematocrit measurement

  Dr. Leonid Livshits, Ms. Tal Bilu, Ms. Sari Peretz, Prof. Anna Bogdanova, Prof. Max Gassmann, Dr. Harel Eitam, Prof. Ariel Koren, Prof. Carina Levin

  e2022049

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.049

  2500

  PDF: 900

  HTML: 968

• Should every patient with MDS get iron chelation – probably yes.

  Kanjaksha Ghosh, Emanuele Angelucci, Federica Pilo, Kinjalka Ghosh

  e2017055

  2017-09-01

  https://doi.org/10.4084/mjhid.2017.055

  2371

  PDF: 983

  HTML: 396

• SUBTYPE DISTRIBUTION AND MUTATION SPECTRUM THALASSEMIA IN CHILDREN UNDER 10 YEARS IN NORTHERN VIETNAM

  Ngoc Dung Nguyen, Ha Thanh Nguyen, Thi Chi Nguyen, Thi Nguyet Anh Phi, Thi Thu Ha Nguyen, Thi Thu Huyen Le, Phuong Linh Hoang, Duc Binh Vu

  e2026002

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.002

  1061

  PDF: 739

  Html: 328

• IMPLEMENTATION OF MICROELIMINATION STRATEGY IN ERADICATION OF CHRONIC HEPATITIS C INFECTION IN PATIENTS WITH HEMOPHILIA IN THE NORTHERN REGION OF SERBIA Microelimination Strategy of Chronic Hepatitis C Infection in patients with Hemophilia

  Maja Ružić, Natalija Rajić, Milotka Fabri, Ivana Urošević, Marina Dragičević Jojkić, Tomislav Preveden, Maria Pete, Nebojša Rajić

  e2021058

  2021-08-29

  https://doi.org/10.4084/MJHID.2021.058

  931

  PDF: 420

  HTML: 154

• THE USE OF HPLC AS A TOOL FOR NEONATAL CORD BLOOD SCREENING OF HAEMOGLOBINOPATHY - A VALIDATION STUDY

  A. Al-Madhani, Anil Pathare, Salam Alkindi

  e2019005

  2019-01-01

  https://doi.org/10.4084/mjhid.2019.005

  2102

  PDF: 1226

  HTML: 402

• ECONOMIC EVALUATION OF CHELATION REGIMENS FOR ?--THALASSEMIA MAJOR: A SYSTEMATIC REVIEW

  Jialian Li

  e2019036

  2019-06-24

  https://doi.org/10.4084/mjhid.2019.036

  2061

  PDF: 1490

  HTML: 236

• SPECTRUM OF BETA GLOBIN GENE MUTATIONS IN EGYPTIAN CHILDREN WITH ?- THALASSEMIA

  MR El-Shanshory, Adel Abd Elhaleim Hagag

  e2014071

  2014-08-28

  https://doi.org/10.4084/mjhid.2014.071

  2115

  PDF: 1072

  HTML: 4285

• Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis

  Marianna Criscuolo, Luana Fianchi, Patrizia Chiusolo, Simona Sica, Livio Pagano

  e2026060

  2026-06-30

  https://doi.org/10.4084/MJHID.2026.060

  2101

  PDF: 116

  HTML: 31

• Hyperbilirubinemia in abo minor mismatch transplantation.

  xiaolin yin

  e2024050

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.050

  558

  PDF: 708

  HTML: 82

• Transfusion associated peak in Hb HPLC chromatogram – a case report

  Sonal Jain, Jasmita Dass, Hara Prasad Pati

  e2012006

  2012-01-21

  https://doi.org/10.4084/mjhid.2012.006

  1137

  PDF: 801

  HTML: 2797

• GLUCOSE METABOLISM AND INSULIN RESPONSE TO ORAL GLUCOSE TOLERANCE TEST (OGTT) IN PREPUBERTAL PATIENTS WITH TRANSFUSION DEPENDENT Β-THALASSEMIA (TDT): A LONG-TERM RETROSPECTIVE ANALYSIS Long-term retrospective analysis of glucose homeostasis in children with transfusion dependent β-thalassemia

  Vincenzo De Sanctis, Ashraf Soliman, Ploutarchos Tzoulis, Shahina Daar, Salvatore Di Maio, Bernadette Fiscina, Christos Kattamis

  e2021051

  2021-08-28

  https://doi.org/10.4084/MJHID.2021.051

  1870

  PDF: 586

  HTML: 247

• BONE MINERAL DENSITY AND VITAMIN D RECEPTOR GENETIC VARIANTS IN EGYPTIAN CHILDREN WITH BETA THALASSEMIA ON VITAMIN D SUPPLEMENTATION

  Hadeer A Abbassy, Reham Abdel Haleem Abo Elwafa, Omneya Magdy Omar

  e2019013

  2019-01-01

  https://doi.org/10.4084/mjhid.2019.013

  2334

  PDF: 1272

  HTML: 210

• ACUTE PROMYELOCYTIC LEUKEMIA: AN EXPERIENCE ON 95 GREEK PATIENTS TREATED IN THE ALL-TRANS-RETINOIC ACID ERA

  Maria Pagoni, Maria Garofalaki, Fotios Panitsas, Kalliopi Manola, Katerina Psarra, Panagiotis Economopoulos

  e2011053

  2011-11-28

  https://doi.org/10.4084/mjhid.2011.053

  2931

  PDF: 923

  HTML: 3605

• A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia

  Vincenzo De Sanctis

  e2025008

  2024-12-31

  https://doi.org/10.4084/MJHID.2025.008

  2994

  PDF: 1381

  HTML: 167

• COMPREHENSIVE REVIEW OF GENETIC AND EPIGENETICS REGULATION OF FETAL HEMOGLOBIN IN β-HEMOGLOBINOPATHIES: FROM MOLECULAR MECHANISMS TO CLINICAL APPLICATIONS HbF Genetics in Anemia

  Yousef Saeed Mohammad Abu Za’ror, Joseph Bagi Suleiman, Fatima Azzahra Delmani, Jehad Farouq Alhmoud, Amer Mohammad Ayasreh, Sarah Ihsan Al-wendawi, Maryam Azlan

  e2026046

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.046

  830

  PDF: 610

  HTML: 103

• Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)

  Salam Alkindi, Dr. , Dr.

  e2021059

  2021-09-01

  https://doi.org/10.4084/MJHID.2021.059

  2218

  PDF: 538

  HTML: 178

• How I treat acute and persistent sickle cell pain

  Samir Ballas

  e2020064

  2020-09-08

  https://doi.org/10.4084/mjhid.2020.064

  2052

  PDF: 1153

  HTML: 693

• A CASE OF CONGENITAL DYSERYTHROPOIETIC ANEMIA MASKED BY HEMOGLOBIN H DISEASE

  Xiaolin Yin

  e2024059

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.059

  785

  PDF: 891

  HTML: 115

• How we prevented an anti-P1 mediated hemolytic transfusion reaction

  Beatrice Borsellino, Tiziano Martini, Rino Biguzzi, Irene Francesconi, Maria Federica Currà, Sabrina Lelli

  e2024009

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.009

  1236

  PDF: 1268

  HTML: 513

• INSULIN-LIKE GROWTH FACTOR-1 (IGF-1): DEMOGRAPHIC, CLINICAL AND LABORATORY DATA IN 120 CONSECUTIVE ADULT PATIENTS WITH THALASSAEMIA MAJOR

  V. De Sanctis

  e2014.074

  2014-11-01

  https://doi.org/10.4084/mjhid.2014.074

  2319

  PDF: 979

  HTML: 26966

• ACTIVIN RECEPTOR LIGAND FOR THR TREATMENT OF BETA-THALASSEMIA: a SERENDIPITOUS DISCOVERY

  Irene Motta, Valentina Brancaleoni, Isabella Nava, Paola Delbini, Lorena Duca

  e2020075

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.075

  1675

  PDF: 1474

  HTML: 612

• THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA

  adel abd elhaleim hagag

  e2013065

  2013-11-04

  https://doi.org/10.4084/mjhid.2013.065

  2801

  PDF: 863

  HTML: 15025

  Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 339

• Spontaneous rupture of malarial spleen: report of two cases

  M Ezzedien Rabie

  e2010036

  2010-12-13

  https://doi.org/10.4084/mjhid.2010.036

  857

  PDF: 422

  HTML: 2888

  jdoe, cover letter.doc: 194

• Impact of daratumumab on stem cell mobilization and transplant in patient with newly diagnosed multiple myeloma: a real word single-center study

  Mauro Passucci, Francesca Fazio, Jacopo Micozzi, Manhaz Shafii Bafti, Giovanni Manfredi Assanto, Alfonso Piciocchi, Maurizio Martelli, Maria Teresa Petrucci

  e2024041

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.041

  1302

  PDF: 1092

  Suppl. Files: 726

  HTML: 84

• THE ROLE OF THE CAROTID DOPPLER EXAMINATION IN THE EVALUATION OF ATHEROSCLEROTIC CHANGES IN BETA THALASSEMIA PATIENTS

  Gehan Lotfy Abdel Hakeem, hoda Abdel kereem Abdel Samei, Ashraf mohamed El Shereif, Ahlam mohamed ismail

  e2015023

  2015-02-17

  https://doi.org/10.4084/mjhid.2015.023

  2241

  PDF: 1021

  HTML: 3067

  Untitled: 240

• A novel ALAS2 mutation causes congenital sideroblastic anemia

  Kun Yang

  e2023062

  2023-10-30

  https://doi.org/10.4084/MJHID.2023.062

  754

  PDF: 592

  HTML: 180

• TREATMENT WITH LOW-DOSE CYTARABINE IN ELDERLY PATIENTS (AGE 70 YEARS OR OLDER) WITH ACUTE MYELOID LEUKEMIA: A SINGLE INSTITUTION EXPERIENCE

  Maël Heiblig, Mohamed Elhamri, Isabelle Tigaud, Adriana Plesa, Fiorenza Barraco, Hélène Labussière, Sophie Ducastelle, Mauricette Michallet, Franck Nicolini, Claudiu Plesa, Eric Wattel, Gilles Salles, Xavier Thomas

  e2016009

  2016-01-01

  https://doi.org/10.4084/mjhid.2016.009

  7606

  PDF: 1561

  HTML: 1657

• FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells

  Eugenio Galli, Filippo Frioni, Tanja Malara, Enrico Attardi, Silvia Bellesi, Stefan Hohaus, Simona Sica, Federica Sorà, Patrizia Chiusolo

  e2024029

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.029

  1037

  PDF: 1268

  HTML: 125

• Common variable immunodeficiency due to a novel NFKB1 variant in a child with thalassemia major CVID with thalassemia major

  Kun Yang

  e2023053

  2023-08-29

  https://doi.org/10.4084/MJHID.2023.053

  777

  PDF: 591

  HTML: 191

• Sickle cell disease and Bartonella spp. infection

  Paulo Eduardo Neves Ferreira Velho, Marna Elise Ericson, David Mair, Kalpna Gupta

  e2012046

  2012-06-30

  https://doi.org/10.4084/mjhid.2012.046

  1356

  PDF: 1396

  HTML: 477

• APLASTIC ANEMIA AND VIRAL HEPATITIS

  Laura Cudillo

  e2009026

  https://doi.org/10.4084/mjhid.2009.026

  1307

  PDF: 546

  HTML: 23142

• HOMOZYGOUS DELETION ALFA-THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, TWO GENETIC FACTORS PREDICTIVE THE REDUCTION OF MORBIDITY AND MORTALITY DURING PREGNANCY IN SICKLE CELL PATIENTS . A REPORT FROM DEMOCRATIC REPUBLIC OF CONGO ALPHA THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN REDUCE MORBIDITY DURING PREGNANCY IN SICKLE CELL PATIENTS

  Tite Minga MIKOBI, Prosper Tshilobo LUKUSA

  e2019039

  2019-06-24

  https://doi.org/10.4084/mjhid.2019.039

  10611

  PDF: 1020

  HTML: 305

• PREVALENCE OF THALASSEMIA IN THE VIETNAMESE POPULATION AND BUILDING A CLINICAL DECISION SUPPORT SYSTEM FOR PRENATAL SCREENING FOR THALASSEMIA

  Danh Cuong Tran, Anh Linh Dang, Thi Ngoc Lan Hoang, Chi Thanh Nguyen, Thi Ngoc Mai Dinh, Van Anh Tran, Thi Kim Phuong Doan, Thi Trang Nguyen

  e2023026

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.026

  4899

  HTML: 335

  PDF: 1365

• Atypical evolution of a Vaso-Occlusive presentation in Sickle Cell Disease: lessons in diagnostic vigilance

  Cristina Giubbilei, Elena Angeli, Fiammetta Fossi, Agnese Baffioni, Ginevra Giustini, Valentina Carrai

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.042

  234

  HTML: 593

  PDF: 164

• A Suspected Case of Cerebral Fat Embolism Triggering a Drug-resistant Status Epilepticus in a HbS/β⁺-Thalassaemia Patient

  Marta Bortolotti, Gianluca Costamagna, Marta Mancarella, Delia Gagliardi, Silvia Lanfranconi, Alessia Marcon, Margherita Migone De Amicis, Nereo Bresolin, Stefania Corti, Giovanna Graziadei

  e2022019

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.019

  1048

  PDF: 589

  HTML: 268

• OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION

  Rafael Rojas, José R. Molina, Isidro Jarque, Miguel A. Sanz

  e2012011

  2012-02-10

  https://doi.org/10.4084/mjhid.2012.011

  1245

  PDF: 563

  HTML: 1705

  Figures: 188

  Fifures Sanz: 196

  tables Sanz: 202

  Untitled: 193

• POST-LOAD PLASMA GLUCOSE INCREASE (PG-GAP) AS A RISK FACTOR FOR DEVELOPING DYSGLYCEMIA IN PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA (Β-TDT): RETROSPECTIVE ANALYSIS OVER 8 YEARS Post load plasma glucose increase and the risk of glucose dysregulation in thalassemia

  Vincenzo De Sanctis, Mohammad Faranoush, Efthymia Vlachaki, Theodora- Maria Venou, Ashraf T Soliman, Shahina Daar, Ploutarchos Tzoulis, Christos Kattamis

  e2025069

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.069

  594

  PDF: 276

  HTML: 165

• INFECTIONS IN MYELODYSPLASTIC SYNDROME IN RELATION TO STAGE AND THERAPY

  Giuseppe Leone, Livio Pagano

  e2018039

  2018-07-01

  https://doi.org/10.4084/mjhid.2018.039

  4395

  PDF: 1489

  HTML: 758

• SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib

  Matteo Molica

  e2024079

  2024-10-31

  https://doi.org/10.4084/MJHID.2024.079

  1010

  PDF: 549

  HTML: 221

• Concordance Rate of Fasting Plasma Glucose (PG) and 2-hour PG post Oral Glucose Tolerance Test (OGTT) in Patients with new diagnosis of Thalassemia-Related Diabetes Mellitus (Th-RDM):Implications for Clinical Practice OGTT concordance rate in thalassemia major

  Vincenzo De Sanctis, Mohammad Faranoush, Shahina Daar, Ihab Elhakim, Ashraf T Soliman, Forough Saki, Mehran Karimi, Ploutarchos Tzoulis

  e2026011

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.011

  768

  PDF: 589

  Html: 138

• Epidemiology and clinical characteristics of Henoch-Schönlein purpura associated with Mycoplasma pneumoniae infection in 131 children in Hubei province, China

  hongbo Hu

  Page e2021037

  2021-04-29

  https://doi.org/10.4084/MJHID.2021.037

  1446

  PDF: 586

  HTML: 294

• NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa

  Alessandro Matte, Filippo Mazzi, Enrica Federti, Oliviero Olivieri, Lucia De Franceschi

  e2019002

  2019-01-01

  https://doi.org/10.4084/mjhid.2019.002

  7071

  PDF: 3759

  HTML: 813

• HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS

  Mazyar Shadman, Joachim Deeg

  e2014056

  2014-09-01

  https://doi.org/10.4084/mjhid.2014.056

  2137

  PDF: 803

  HTML: 3255

• Could the 3′UTR+101G>C Mutation Detected in Two Sibling Cases Be a Mutation Affecting the Clinical Presentation in Thalassemia Patients?

  Unal Atas, Volkan Karakus, Erdal Kurtoglu

  e2024023

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.023

  609

  PDF: 1109

  HTML: 106

• MODULATING EFFECT OF THE ?158 G? (C?T) XMN-1 POLYMORPHISM IN INDIAN SICKLE CELL PATIENTS

  Sanjay Pandey, Sweta Pandey, Rahasya Mani Mishra, Renu Saxena

  e2012001

  2012-01-15

  https://doi.org/10.4084/mjhid.2012.001

  1606

  PDF: 929

  HTML: 1446

  Table: 214

• JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia

  Phakatip Sinlapamongkolkul, Pacharapan Surapolchai, Vip Viprakasit

  e2023056

  2023-08-29

  https://doi.org/10.4084/MJHID.2023.056

  3255

  PDF: 643

  Suppl. Files: 302

  HTML: 276